CEPI-U.S. for CEPI-U.S.
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Education and advocacy supporting the mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.1319, American Rescue Plan Act of 2021, Sec. 10002, United States Agency for International Development Operations H.R.2118, Securing America From Epidemics Act, Sec. 3, Authorization for United States Participation H.R.4350, FY22 National Defense Authorization Act, Sec. 6427, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations H.R.4373, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022, Title 3, all provisions relating to global health programs S. 1605, FY22 National Defense Authorization Act, Sec. 6501, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations S.2297 - International Pandemic Preparedness and COVID-19 Response Act of 2021, Sec. 208, Authorization for U.S. Participation in the Coalition for Epidemic Preparedness Innovations Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022
Foreign entity interest: The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL SKALLMAN | — |
| RICHARD WILDER | — |
Foreign Relations FOR
Education and advocacy supporting the mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.1319, American Rescue Plan Act of 2021, Sec. 10002, United States Agency for International Development Operations H.R.2118, Securing America From Epidemics Act, Sec. 3, Authorization for United States Participation H.R.4350, FY22 National Defense Authorization Act, Sec. 6427, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations H.R.4373, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022, Title 3, all provisions relating to global health programs S. 1605, FY22 National Defense Authorization Act, Sec. 6501, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations S.2297 - International Pandemic Preparedness and COVID-19 Response Act of 2021, Sec. 208, Authorization for U.S. Participation in the Coalition for Epidemic Preparedness Innovations Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022
Foreign entity interest: The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL SKALLMAN | — |
| RICHARD WILDER | — |
Budget/Appropriations BUD
Education and advocacy supporting the mission of the Coalition for Epidemic Preparedness Innovations (CEPI), including development of vaccines for emerging diseases to help prevent and respond to epidemics and pandemics and strengthen global health security. H.R.1319, American Rescue Plan Act of 2021, Sec. 10002, United States Agency for International Development Operations H.R.2118, Securing America From Epidemics Act, Sec. 3, Authorization for United States Participation H.R.4350, FY22 National Defense Authorization Act, Sec. 6427, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations H.R.4373, Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022, Title 3, all provisions relating to global health programs S. 1605, FY22 National Defense Authorization Act, Sec. 6501, Authorization for United States participation in the Coalition for Epidemic Preparedness Innovations S.2297 - International Pandemic Preparedness and COVID-19 Response Act of 2021, Sec. 208, Authorization for U.S. Participation in the Coalition for Epidemic Preparedness Innovations Senate Department of State, Foreign Operations, and Related Programs Appropriations Act, 2022
Foreign entity interest: The Coalition for Epidemic Preparedness Innovations (CEPI) is based in Norway, and its mission is to promote the development and availability of vaccines against emerging epidemic and pandemic diseases. Lobbying efforts by CEPI-U.S. will support that mission.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL SKALLMAN | — |
Foreign entities
Foreign owners and affiliates the filer disclosed. Amounts are as declared on this filing.
| Entity | Country | Principal place of business | Ownership | Contribution declared |
|---|---|---|---|---|
| COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS | Norway | Norway | 100.0% | $50,000 |
Affiliated organisations
| Organisation | Location |
|---|---|
| COALITION FOR EPIDEMIC PREPAREDNESS INNOVATIONS | Oslo, NO |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.